Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Viikinkaari 6, Helsinki,uusimaa 00790,finland
- Phone
- +44 20 3920 7649
- in****@****otx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- valotx.com
- HQ
- Helsinki, Uusimaa
Valo Therapeutics Ltd Questions
Valo Therapeutics Ltd's helpline number is +44 20 3920 7649
Valo Therapeutics Ltd's website is valotx.com
Valo Therapeutics Ltd's LinkedIn profile is https://fi.linkedin.com/company/valo-therapeutics
Valo Therapeutics Ltd has
19 employees.
View email and phone details for 19
employees at Valo Therapeutics Ltd.
Valo Therapeutics Ltd's industry is
Biotechnology Research
Valo Therapeutics Ltd's top competitors are
Herantis Pharma Plc.,
Biohit Oyj,
Nanoform,
Faron,
Aidian,
Orion Pharma,
Finvector Oy,
Tilt Biotherapeutics Ltd,
Medfiles,
Medix Biochemica.
Valo Therapeutics Ltd's support email address is info@valotx.com
Valo Therapeutics Ltd's categories are Biotechnology Research
Valo Therapeutics Ltd's founding year is 2016
